Monograph
S02CA02 - Flumetasone and Antiinfectives |
Propably not porphyrinogenic |
PNP |
Rationale
Probably no significant metabolic load.
Chemical description
Ear drops with moderately strong glucocorticoid (flumethasone: NP) combined with antibiotic/ antimycotic Vioform (cliochinol 10 mg/mL, no data on metabolism: PSP). Less than 5% of the dose is absorbed.
IPNet drug reports
Uneventful use reported in 1 patient with acute porphyria.
Similar drugs
Tradenames and packages
From some sources, we get a list of packages (United Kingdom, Ireland, Estonia).
Other sources contain more or less "clean" versions of the trade name (Denmark, Finland, Iceland, Lithuania, Norway).
What you see here is the raw data we get from each country, so there will appear to be duplicates. The bold names
are the searchable terms. The gray names that follow are all mapped to the bolded term.
Note: The cleaning is done automatically by a proprietary algorithm, and it may produce errors.
We strive to improve it continuously.
Netherlands
Locacorten-Vioform · Locacorten-Vioform, oordruppelsUnited Kingdom
Flumetasone · Flumetasone 0.02% / Clioquinol 1% ear drops · Locorten Vioform · Locorten Vioform ear dropsDenmark
Locacorten-VioformFinland
Locacorten-Vioform
© NAPOS 2024